Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,130.00
+45.00 (1.10%)
Apr 8, 2026, 3:30 PM KST

Yuyu Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
65,03771,10072,90385,445102,750130,082
Market Cap Growth
-11.57%-2.47%-14.68%-16.84%-21.01%20.23%
Enterprise Value
73,76084,95276,861119,950114,352120,293
Last Close Price
4130.004515.004391.645032.115927.987320.64
PE Ratio
8.598.728.36---
PS Ratio
0.460.510.550.620.741.13
PB Ratio
0.460.510.540.710.831.01
P/TBV Ratio
0.520.570.610.810.931.11
P/FCF Ratio
8.539.324.09---
P/OCF Ratio
4.104.482.92203.03-28.85
EV/Sales Ratio
0.520.600.580.870.821.04
EV/EBITDA Ratio
4.295.114.2124.6925.7821.09
EV/EBIT Ratio
6.367.716.11--100.23
EV/FCF Ratio
9.6711.144.31---
Debt / Equity Ratio
0.200.200.250.330.320.30
Debt / EBITDA Ratio
1.681.681.848.118.866.87
Debt / FCF Ratio
3.663.661.89---
Net Debt / Equity Ratio
-0.03-0.03-0.070.060.07-0.09
Net Debt / EBITDA Ratio
-0.29-0.29-0.491.451.92-1.95
Net Debt / FCF Ratio
-0.63-0.63-0.50-1.72-0.747.09
Asset Turnover
0.680.680.660.700.720.67
Inventory Turnover
2.162.161.982.112.642.89
Quick Ratio
0.890.890.971.140.862.43
Current Ratio
1.641.641.582.031.503.30
Return on Equity (ROE)
6.62%6.62%8.06%-4.55%-3.51%-0.75%
Return on Assets (ROA)
3.32%3.32%3.88%-0.24%-0.19%0.43%
Return on Invested Capital (ROIC)
7.70%8.09%9.93%-0.58%-0.47%1.03%
Return on Capital Employed (ROCE)
7.40%7.40%8.80%-0.50%-0.50%0.70%
Earnings Yield
12.54%11.47%11.96%-8.40%-5.83%-1.70%
FCF Yield
11.72%10.72%24.47%-4.79%-11.20%-1.20%
Payout Ratio
23.66%23.66%----
Buyback Yield / Dilution
0.27%0.27%-4.49%1.89%-3.90%-32.81%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.